π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride, b...
Status
Terminated
Location
Stanford Cancer Center
Start Date
2013-05-24
Trial ID
NCT01390584
The first testing of TargomiRs in the human setting: dose-finding studies i...
Status
Completed
Location
Concord Repatriation General Hospital
Start Date
2014-09
Trial ID
NCT02369198
Treatments Being Tested
The study is an open label, non-randomized study designed to evaluate the d...
Status
Terminated
Location
Johns Hopkins University
Start Date
2019-11-15
Trial ID
NCT03619655
Treatments Being Tested
This study is being done to find out how effective a new treatment strategy...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2008-08
Trial ID
NCT00737438
Treatments Being Tested
This phase II trial examines the use of blood-based biomarkers is to help i...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2023-02-21
Trial ID
NCT05541016
Treatments Being Tested
The purpose of this study is to assess the feasibility of investigational P...
Status
Unknown
Location
Martha Morehouse Medical Plaza
Start Date
2017-09-19
Trial ID
NCT03387618
Treatments Being Tested
The investigators want to compare the use of MRI with PET/CT preformed afte...
Status
Unknown
Location
Department of Nuclear Medicine
Start Date
2013-08
Trial ID
NCT01889615
Treatments Being Tested
Dementia with Lewy Body (DLB) is a common neurodegenerative disorder respon...
Status
Unknown
Location
Multiple Locations
Start Date
2019-12-14
Trial ID
NCT04154215
Treatments Being Tested
This study plans to include LARC patients receiving neoadjuvant therapy at ...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2024-07-01
Trial ID
NCT06653452
Treatments Being Tested
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2023-06-12
Trial ID
NCT05633615